Beta Drugs (India) Alpha and Beta Analysis

BETA Stock   2,143  103.15  4.59%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Beta Drugs. It also helps investors analyze the systematic and unsystematic risks associated with investing in Beta Drugs over a specified time horizon. Remember, high Beta Drugs' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Beta Drugs' market risk premium analysis include:
Beta
0.58
Alpha
0.54
Risk
3.54
Sharpe Ratio
0.11
Expected Return
0.39
Please note that although Beta Drugs alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Beta Drugs did 0.54  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Beta Drugs stock's relative risk over its benchmark. Beta Drugs has a beta of 0.58  . As returns on the market increase, Beta Drugs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Beta Drugs is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Beta Drugs Backtesting, Beta Drugs Valuation, Beta Drugs Correlation, Beta Drugs Hype Analysis, Beta Drugs Volatility, Beta Drugs History and analyze Beta Drugs Performance.

Beta Drugs Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Beta Drugs market risk premium is the additional return an investor will receive from holding Beta Drugs long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Beta Drugs. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Beta Drugs' performance over market.
α0.54   β0.58

Beta Drugs expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Beta Drugs' Buy-and-hold return. Our buy-and-hold chart shows how Beta Drugs performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Beta Drugs Market Price Analysis

Market price analysis indicators help investors to evaluate how Beta Drugs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Beta Drugs shares will generate the highest return on investment. By understating and applying Beta Drugs stock market price indicators, traders can identify Beta Drugs position entry and exit signals to maximize returns.

Beta Drugs Return and Market Media

The median price of Beta Drugs for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 1801.9 with a coefficient of variation of 10.17. The daily time series for the period is distributed with a sample standard deviation of 186.28, arithmetic mean of 1832.48, and mean deviation of 154.93. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Why Investors Shouldnt Be Surprised By Beta Drugs Limiteds 30 percent Share Price Surge - Simply Wall St
11/07/2024

About Beta Drugs Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Beta or other stocks. Alpha measures the amount that position in Beta Drugs has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Beta Drugs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Beta Drugs' short interest history, or implied volatility extrapolated from Beta Drugs options trading.

Build Portfolio with Beta Drugs

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Beta Stock Analysis

When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.